TREA

88404466 - MEDINCELL

Follow

Information

  • Trademark
  • 88404466
  • Serial Number
    88404466
  • Registration Number
    6077768
  • Filing Date
    April 26, 2019
    5 years ago
  • Registration Date
    June 16, 2020
    4 years ago
  • Transaction Date
    June 16, 2020
    4 years ago
  • Status Date
    June 16, 2020
    4 years ago
  • Published for Opposition Date
    March 31, 2020
    4 years ago
  • Location Date
    June 16, 2020
    4 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    IM, JEAN H
  • Attorney Docket Number
    07626-T0002A
    Attorney Name
    Stephen P. McNamara
    Law Office Assigned Location Code
    L10
  • Owners
Information
Mark Drawing Code
3000
Mark Identification
MEDINCELL
Case File Statements
  • CC0000: The color(s) black and blue is/are claimed as a feature of the mark.
  • DM0000: The mark consists of the word "MedinCell" in black letters with a blue design consisting of two horizontally oriented conjoined semi-circles located above the word "Cell" with a single vertically oriented semi-circle conjoined to the right of the two horizontally oriented conjoined semi-circles.
  • GS0051: Pharmaceutical preparations and substances for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders; pharmaceutical preparations, namely, a drug delivery system comprising pharmaceutical compositions for subcutaneous or intraarticular administration for the continuous release of therapeutic agents for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders; veterinary preparations and substances for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders; veterinary preparations, namely, a drug delivery system comprising compositions that facilitate continuous release delivery of a wide variety of therapeutic subcutaneous or intraarticular veterinary agents; pharmaceutical compositions for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceutical and veterinary pharmaceutical preparations; Drug delivery agents in the form of compounds that facilitate controlled release delivery of subcutaneous or intraarticular active ingredients for a wide variety of pharmaceuticals and veterinary pharmaceutical preparations; Drug delivery agents in the form of drug delivery compounds that facilitate sustained or extended release of the active ingredients for a wide variety of pharmaceuticals and veterinary pharmaceutical preparations; Drug delivery agents in the form of compounds that facilitate delivery of injectable pharmaceutical and veterinary pharmaceutical preparations; sustained or extended release drug delivery agents being compounds used to facilitate delivery of drugs, sold as an integral component of pharmaceutical and veterinary pharmaceutical preparations for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders; chemical preparations for medical or pharmaceutical use for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders; Carriers and mediums being drug delivery agents comprised of compounds for facilitating the delivery of pharmaceutical and veterinary pharmaceutical preparations for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders; pharmaceutical and veterinary pharmaceutical preparations and substances for subcutaneous delivery for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders
Case File Event Statements
  • 6/16/2020 - 4 years ago
    21 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 3/31/2020 - 4 years ago
    20 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 3/31/2020 - 4 years ago
    19 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 3/11/2020 - 4 years ago
    18 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 2/27/2020 - 4 years ago
    17 - ELECTRONIC RECORD REVIEW COMPLETE Type: FIXD
  • 2/7/2020 - 4 years ago
    16 - ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED Type: ERRR
  • 1/31/2020 - 4 years ago
    15 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 1/31/2020 - 4 years ago
    14 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 1/31/2020 - 4 years ago
    13 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 1/31/2020 - 4 years ago
    12 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 1/31/2020 - 4 years ago
    11 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 1/9/2020 - 4 years ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 1/8/2020 - 4 years ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 1/8/2020 - 4 years ago
    8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 7/10/2019 - 4 years ago
    7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 7/10/2019 - 4 years ago
    6 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 7/10/2019 - 4 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 7/9/2019 - 4 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 5/15/2019 - 5 years ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 5/14/2019 - 5 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 4/30/2019 - 5 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP